Bard Lawsuit News and Information
Women who have had a Bard Avaulta vaginal mesh implanted to treat pelvic organ prolapse could be at risk for severe internal injuries, urinary problems, and other complications. Bard Avaulta lawsuits allege that the defective design of the device may increase the risk of infections, erosion and other painful complications.
All Articles Tagged With: "Bard"
Vaginal mesh bellwether trials are scheduled well into next year and could determine the outcome of ongoing settlement negotiations.
Due to a risk of loss of limb, or even death, the FDA has announced a class I recall for Bard LifeStent Solo Vascular Stents.
The first bellwether Ethicon vaginal mesh trials will go before a jury in February involving Gynecare TVT mesh.
Settlement talks are reportedly under way with a number of vaginal mesh manufacturers that could resolve thousands of claims.
More than 30,000 lawsuits are in 6 different federal vaginal mesh MDLs, and two are among the top 3 active MDLs in the U.S.
Bard has settled a second Avaulta vaginal mesh lawsuit, less than a month after $2 million loss in first bellwether trial.
The second Bard Avaulta trial ended before it began when C.R. Bard reached an undisclosed settlement with the plaintiff.
A federal jury awarded $2 million in the first trial over the Bard Avaulta vaginal mesh.
The first federal Bard Avaulta transvaginal mesh lawsuit is now in the hands of a jury, as deliberations began Wednesday.
Bard engineer testifies that the company knew about vaginal mesh problems since at least 2002
Contact a LawyerSubmit information about your potential case to be reviewed by an attorney.